CompletedPhase 1NCT02736695
Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia
Studying Behavioral variant of frontotemporal dementia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mayo Clinic
- Principal Investigator
- Keith A Josephs, M.D., M.DMayo Clinic
- Intervention
- F-18 AV 1451(drug)
- Enrollment
- 81 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2016 – 2024
Study locations (1)
- Mayo Clinic, Rochester, Minnesota, United States
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02736695 on ClinicalTrials.govOther trials for Behavioral variant of frontotemporal dementia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07531732Links Between Self-awareness and Sociocognitive Processes in Neurodegenerative DiseasesAssistance Publique - Hôpitaux de Paris
- RECRUITINGPHASE2NCT06604520Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal DementiaJohns Hopkins University
- RECRUITINGPHASE2NCT05742698Nabilone for Agitation in Frontotemporal DementiaSimon Ducharme, MD
- RECRUITINGNANCT06706687A Study of the Behavioral Variant of Frontotemporal Dementia and Bipolar Disorder: a Neuroimaging and Epigenetics Integrated ApproachFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- ENROLLING BY INVITATIONNCT04680130Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related DisordersMayo Clinic
See all trials for Behavioral variant of frontotemporal dementia →